ATE40946T1 - Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie. - Google Patents

Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie.

Info

Publication number
ATE40946T1
ATE40946T1 AT84102485T AT84102485T ATE40946T1 AT E40946 T1 ATE40946 T1 AT E40946T1 AT 84102485 T AT84102485 T AT 84102485T AT 84102485 T AT84102485 T AT 84102485T AT E40946 T1 ATE40946 T1 AT E40946T1
Authority
AT
Austria
Prior art keywords
prophylactic agent
epilepsy
medicinal
treatment
remedial
Prior art date
Application number
AT84102485T
Other languages
German (de)
English (en)
Inventor
Norio Ogawa
Shuji Tsukamoto
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE40946T1 publication Critical patent/ATE40946T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT84102485T 1983-03-08 1984-03-08 Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie. ATE40946T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58036568A JPS59163316A (ja) 1983-03-08 1983-03-08 けいれんの治療・予防剤
EP84102485A EP0118132B1 (en) 1983-03-08 1984-03-08 A remedial or prophylactic agent for the treatment of seizures

Publications (1)

Publication Number Publication Date
ATE40946T1 true ATE40946T1 (de) 1989-03-15

Family

ID=12473362

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84102485T ATE40946T1 (de) 1983-03-08 1984-03-08 Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie.

Country Status (5)

Country Link
US (1) US4491594A (forum.php)
EP (1) EP0118132B1 (forum.php)
JP (1) JPS59163316A (forum.php)
AT (1) ATE40946T1 (forum.php)
DE (1) DE3476847D1 (forum.php)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
US4885167A (en) * 1985-04-19 1989-12-05 Board Of Regents, The University Of Texas System Restoration of impaired cardiac function of patients with diverse muscular dystrophies by therapy with coenzyme Q10
US6461593B1 (en) * 1992-02-19 2002-10-08 Biomedical And Clinical Research Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
US5343512A (en) * 1992-03-27 1994-08-30 Motorola, Inc. Call setup method for use with a network having mobile end users
DK0643775T3 (da) * 1992-05-28 2004-09-06 Ct For Molecular Biology And M Quinonderivater til forbedring af cellebioenergi
CN100391447C (zh) * 2004-01-15 2008-06-04 范敏华 一种辅酶q10冻干粉针剂及其制备方法
US20060111743A1 (en) * 2004-11-19 2006-05-25 Gurney Harry C Jr Method for arresting seizure activity
WO2006130775A2 (en) * 2005-06-01 2006-12-07 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers
US7838526B2 (en) * 2005-08-05 2010-11-23 Esther Baldinger Method of treating neurological disorders
JP2009508867A (ja) * 2005-09-15 2009-03-05 エジソン ファーマシューティカルズ， インコーポレイテッド ミトコンドリア病および関連した様態の治療ならびにエネルギーバイオマーカーの調節のための酸化還元活性治療剤のテイル改変体
JP5374162B2 (ja) 2006-02-22 2013-12-25 エジソン ファーマシューティカルズ， インコーポレイテッド ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
EP3827815B1 (en) 2008-09-10 2023-09-06 PTC Therapeutics, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
MX391378B (es) 2015-12-17 2025-03-21 Ptc Therapeutics Inc Derivados de fluoroalquil-, fluoroalcoxi-, fenoxi-, heteroariloxi-, alcoxi- y amina-1,4-benzoquinona para tratamiento de trastornos de estres oxidativo.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534137A (en) * 1965-09-30 1970-10-13 Takeda Chemical Industries Ltd Method of systemic therapy for severe early destructive periodontal disease
US3452144A (en) * 1966-03-26 1969-06-24 Takeda Chemical Industries Ltd Method for treatment of congestive heart failure with coenzyme qn
JPS5845403B2 (ja) * 1976-02-14 1983-10-08 エーザイ株式会社 補酵素ｑを主成分とする膵機能亢進剤
JPS5942649B2 (ja) * 1976-02-14 1984-10-16 エーザイ株式会社 重症筋無力症治療剤
JPS5938202B2 (ja) * 1976-03-05 1984-09-14 エーザイ株式会社 難聴治療剤

Also Published As

Publication number Publication date
US4491594A (en) 1985-01-01
EP0118132A3 (en) 1985-11-06
JPS59163316A (ja) 1984-09-14
JPH0133082B2 (forum.php) 1989-07-11
EP0118132A2 (en) 1984-09-12
EP0118132B1 (en) 1989-03-01
DE3476847D1 (en) 1989-04-06

Similar Documents

Publication Publication Date Title
MY100343A (en) Amide derivative and external medicament comprising same
CA1273019C (en) ENKEPHALINASE INHIBITORS
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE226014T1 (de) Prophylaktische behandlung der allergischen kontaktdermatitis
DE3263057D1 (en) Hair treatment compositions
ATE72448T1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
ATE40946T1 (de) Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie.
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
NZ299727A (en) Preparation of valproic acid analogues and its use for treatment of epilepsy
IE43396L (en) Oxazolidinones
DE69314463D1 (de) Hautregenerierende kosmetische zusammensetzung
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
NO173137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser
SE7702130L (sv) Forfarande for framstellning av n-(merkaptoacyl)-histidiner
PT69999A (de) 1,2,3-triazolcarbonsaureamide verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ES460621A1 (es) Procedimiento de sintesis de n-(1'-alil-2'-pirrolidilmetil)-2,3-dimetoxi-5-sulfamoilbenzamida.
ATE167399T1 (de) Verwendung von sulfasalazin und/oder dessen aktiven metaboliten zur herstellung eines arzneimittels zur behandlung von venöser insuffizienz und venösen ulcera
JPS5218832A (en) Method of making cosmetic preparation
YU17999A (sh) Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee